Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Moleculera Biosciences logo — A Precision Medicine Company.

Moleculera Biosciences

A Precision Medicine Company.

Founded 2011 United States Oklahoma City, United States 15 employees Series Unknown Total: $6.18M Biotechnology, Health Care

General Information

Company Name Moleculera Biosciences
Founded Year 2011
Location United States Oklahoma City, United States +1
Employees 15
Industries Biotechnology, Health Care
Funding Stage Series Unknown
Social

Get notified when Moleculera Biosciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Moleculera Biosciences

Moleculera Labs is a biotechnology startup established in 2011, based in the United States. The company's slogan "Pioneering Research. Life-Changing Tests." reflects its dedication to advancing research in autoimmune neurobiology. Moleculera Labs operates a fully-accredited CLIA/COLA clinical laboratory and specializes in providing advanced testing services. Their flagship offering, The Cunningham Panel™, assists physicians in diagnosing autoimmune-based neuropsychiatric disorders, such as obsessive-compulsive behaviors, tics, anxiety, attention deficit hyperactivity disorder, and behaviors related to Autism Spectrum Disorders caused by molecular mimicry triggered by common infections. This groundbreaking testing service has garnered significant attention in the medical community. Moreover, Moleculera Labs is actively involved in research focused on the autoimmune nature of other neuropsychiatric conditions, including depression, schizophrenia, and bipolar disorder. The company received a notable $1.06M Venture Round investment on 19 May 2015 from investors SeedStep Angels, i2E, i2i, Inc. This investment underscores the confidence of venture capital firms in the potential impact of Moleculera Labs' pioneering research and diagnostic services in the field of autoimmune neurobiology. With its innovative approach and strong investor backing, Moleculera Labs is poised to bring about significant advancements in the diagnosis and treatment of autoimmune-based neuropsychiatric disorders, promising to make a substantial impact on the healthcare industry.

Taxonomy: Clinical Laboratory Services, Autoimmune Disorders, Neurology, Psychiatry, Precision Medicine, Autoimmune Testing, Neuropsychiatric Disorders, Molecular Biology, Autoimmune Cardiovascular Disease, Long-COVID, Medical Diagnostics, Research and Development, Biobanking, Infectious Triggers

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 3
Investor Investor
•••• •••• 		19 May 2015
Venture Round •••••• - 18 Oct 2013
Seed Round •••••• 3
Investor Investor
•••• •••• 		03 Oct 2013
Debt Financing •••••• - 30 Oct 2012

Moleculera Biosciences Alternatives & Competitors

Moleculera Biosciences vs
IpiNovyx Bio
IpiNovyx Bio United States

We are a drug platform focused on treating autoimmune and inflammatory diseases.

Seed
6 employees
Biopharma, Biotechnology
Moleculera Biosciences vs
Greywolf Therapeutics
Greywolf Therapeutics United Kingdom

We are advancing novel antigen modulation technology that controls T cells to guide the immune syste...

Series B
49 employees
Biotechnology, Health Care
Moleculera Biosciences vs
Annexon Biosciences
Annexon Biosciences United States

Unlocking the Next Generation of Complement Therapies

IPO
111 employees
Biotechnology, Health Care

FAQ About Moleculera Biosciences

A Precision Medicine Company.
Moleculera Biosciences was founded in 2011.
Moleculera Biosciences is headquartered in Oklahoma City, United States.
Moleculera Biosciences operates in the following industries: Biotechnology, Health Care.
Moleculera Biosciences has approximately 15 employees.
Moleculera Biosciences has completed 4 funding rounds, raising a total of $6.18M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Moleculera Biosciences include IpiNovyx Bio, Greywolf Therapeutics, Annexon Biosciences, Cognigenics, Neumora. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Moleculera Biosciences and IpiNovyx Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Moleculera Biosciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes